|
CA3100276A1
(en)
|
2018-06-06 |
2019-12-12 |
Massachusetts Institute Of Technology |
Circular rna for translation in eukaryotic cells
|
|
MX2023007137A
(es)
*
|
2020-12-21 |
2023-08-28 |
Beam Therapeutics Inc |
Nanomateriales que comprenden acetales unidos a ésteres.
|
|
CN115997018A
(zh)
|
2021-03-10 |
2023-04-21 |
尔知渃米斯股份有限公司 |
自身环化rna构建体
|
|
CA3211623A1
(en)
|
2021-05-24 |
2022-12-01 |
Bo YING |
Lipid compounds and lipid nanoparticle compositions
|
|
CN113264842B
(zh)
*
|
2021-07-21 |
2022-03-01 |
苏州科锐迈德生物医药科技有限公司 |
一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
|
|
TW202328067A
(zh)
|
2021-09-14 |
2023-07-16 |
美商雷納嘉德醫療管理公司 |
環狀脂質及其使用方法
|
|
CN118317944A
(zh)
|
2021-09-14 |
2024-07-09 |
雷纳嘉德医疗管理公司 |
非环状脂质及其使用方法
|
|
MX2024006440A
(es)
|
2021-11-24 |
2024-08-19 |
Flagship Pioneering Innovations Vi Llc |
Composiciones inmunogenicas y sus usos.
|
|
EP4436984A1
(en)
|
2021-11-24 |
2024-10-02 |
Flagship Pioneering Innovations VI, LLC |
Coronavirus immunogen compositions and their uses
|
|
AU2022397292A1
(en)
|
2021-11-24 |
2024-05-30 |
Flagship Pioneering Innovations Vi, Llc |
Varicella-zoster virus immunogen compositions and their uses
|
|
JP2024543272A
(ja)
*
|
2021-11-29 |
2024-11-20 |
ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント |
マルチモチーフデンドロン及びその超分子構造ならびにその使用
|
|
WO2023126053A1
(en)
*
|
2021-12-28 |
2023-07-06 |
BioNTech SE |
Lipid-based formulations for administration of rna
|
|
CN114349811A
(zh)
*
|
2022-01-05 |
2022-04-15 |
上海交通大学 |
阳离子胆固醇衍生物、纳米复合物及其制备方法和应用
|
|
WO2023138666A1
(en)
*
|
2022-01-19 |
2023-07-27 |
Utc Therapeutics (Shanghai) Co., Ltd. |
Circular rna and use thereof
|
|
EP4482819A2
(en)
*
|
2022-02-24 |
2025-01-01 |
Vivasor, Inc. |
Novel ionizable cationic lipids
|
|
US20250188028A1
(en)
*
|
2022-03-14 |
2025-06-12 |
Nanovation Therapeutics Inc. |
Synthetic Method for Producing Ionizable Amino Lipids
|
|
CN118871134A
(zh)
*
|
2022-03-21 |
2024-10-29 |
生物探险有限公司 |
用于增强蛋白质表达的内部核糖体进入位点（IRES）、质粒载体和环状mRNA
|
|
KR102560772B1
(ko)
*
|
2022-03-21 |
2023-07-28 |
주식회사 메디치바이오 |
신규한 이온화지질 및 이를 이용한 지질나노입자 조성물
|
|
TW202408542A
(zh)
*
|
2022-05-20 |
2024-03-01 |
大陸商浙江健新原力製藥有限公司 |
製備環狀ｒｎａ的方法
|
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
|
CN119343454A
(zh)
*
|
2022-09-13 |
2025-01-21 |
苏州艾博生物科技有限公司 |
用于合成环状rna的一步法
|
|
EP4596605A4
(en)
*
|
2022-09-30 |
2026-01-14 |
Xiamen Sinopeg Biotech Co Ltd |
PEGYLATED LIPID CONTAINING A LYSIN NUCLEUS
|
|
CN117917398A
(zh)
*
|
2022-10-21 |
2024-04-23 |
华中师范大学 |
一种可离子化脂质化合物、核酸药物分子递送系统及应用
|
|
CN120390656A
(zh)
|
2022-11-08 |
2025-07-29 |
欧纳医疗公司 |
环状rna组合物
|
|
CN120225500A
(zh)
*
|
2022-11-18 |
2025-06-27 |
韩国生命工学研究院 |
用于活性物质递送的脂质化合物及组合物
|
|
AU2023398825A1
(en)
|
2022-12-15 |
2025-06-26 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
CN120390801A
(zh)
*
|
2022-12-20 |
2025-07-29 |
杭州明德生物医药技术有限公司 |
环状rna分离和纯化方法
|
|
EP4642434A2
(en)
*
|
2022-12-29 |
2025-11-05 |
Life Technologies Corporation |
Lipid compositions on the basis of ionizable lipids, use for delivery to immune cells
|
|
WO2024151583A2
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations Vii, Llc |
Vaccines and related methods
|
|
WO2024167885A1
(en)
|
2023-02-06 |
2024-08-15 |
Flagship Pioneering Innovations Vii, Llc |
Immunomodulatory compositions and related methods
|
|
WO2024192420A1
(en)
|
2023-03-15 |
2024-09-19 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising polyribonucleotides and uses thereof
|
|
WO2024192291A1
(en)
|
2023-03-15 |
2024-09-19 |
Renagade Therapeutics Management Inc. |
Delivery of gene editing systems and methods of use thereof
|
|
EP4680595A2
(en)
|
2023-03-15 |
2026-01-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
EP4680276A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
KR20240159310A
(ko)
*
|
2023-04-28 |
2024-11-05 |
주식회사 메디치바이오 |
신규한 이온화지질을 이용한 지질나노입자 조성물
|
|
EP4698150A1
(en)
|
2023-04-19 |
2026-02-25 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220752A2
(en)
*
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024233308A2
(en)
|
2023-05-05 |
2024-11-14 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
US12311033B2
(en)
|
2023-05-31 |
2025-05-27 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
WO2025011502A1
(zh)
*
|
2023-07-07 |
2025-01-16 |
仁景(苏州)生物科技有限公司 |
制备环状rna方法及用于所述方法的核酸序列
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
AU2024335327A1
(en)
|
2023-09-01 |
2026-03-26 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
|
WO2025081042A1
(en)
|
2023-10-12 |
2025-04-17 |
Renagade Therapeutics Management Inc. |
Nickase-retron template-based precision editing system and methods of use
|
|
WO2025085695A1
(en)
*
|
2023-10-18 |
2025-04-24 |
Trustees Of Dartmouth College |
Lipid nanoparticle formulations for delivery of nucleic acids to primary human b-cells
|
|
WO2025101501A1
(en)
|
2023-11-07 |
2025-05-15 |
Orna Therapeutics, Inc. |
Circular rna compositions
|
|
EP4559898A1
(en)
*
|
2023-11-24 |
2025-05-28 |
AldexChem Kft. |
Novel ionizable cationic lipids containing thioether linkage
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025120230A1
(en)
|
2023-12-07 |
2025-06-12 |
T-Curx Gmbh |
Method of producing leukocytes expressing artificial antigen receptors
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025155753A2
(en)
|
2024-01-17 |
2025-07-24 |
Renagade Therapeutics Management Inc. |
Improved gene editing system, guides, and methods
|
|
TW202545974A
(zh)
|
2024-01-26 |
2025-12-01 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
免疫受體抑制蛋白及相關方法
|
|
WO2025174765A1
(en)
|
2024-02-12 |
2025-08-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025240680A1
(en)
|
2024-05-16 |
2025-11-20 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor inhibitory proteins and related methods
|
|
WO2025245111A1
(en)
|
2024-05-22 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor targeting proteins and related methods
|
|
WO2025250751A1
(en)
|
2024-05-31 |
2025-12-04 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2026003582A2
(en)
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026006687A1
(en)
*
|
2024-06-28 |
2026-01-02 |
Orbital Therapeutics, Inc. |
Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus
|
|
WO2026006593A1
(en)
|
2024-06-28 |
2026-01-02 |
Orna Therapeutics, Inc. |
Synthetic internal ribosome entry sites
|
|
WO2026072709A1
(en)
|
2024-09-25 |
2026-04-02 |
Orna Therapeutics, Inc. |
Chimeric antigen receptors targeting bcma
|